Skip to main content

Research Repository

Advanced Search

The therapeutic potential of oxyhydrogen gas in oncology: A study on Epstein–Barr Virus-immortalised B-lymphoblastoid (TK6) cells

Russell, Grace; Thomas, Adam D.; Nenov, Alexander; Mannings, Georgia; Hancock, John T.

The therapeutic potential of oxyhydrogen gas in oncology: A study on Epstein–Barr Virus-immortalised B-lymphoblastoid (TK6) cells Thumbnail


Authors

Grace Russell

Adam Thomas Adam7.Thomas@uwe.ac.uk
Senior Lecturer in Human Genetics and Genomics

Alexander Nenov

Georgia Mannings

Profile image of John Hancock

John Hancock John.Hancock@uwe.ac.uk
Professor in Cell Signalling



Abstract

Cancer is a leading cause of mortality worldwide. B-cells are a keystone of the adaptive immune response and are essential for the presentation of tumor-associated antigens to various types of T-cells. Approximately 1.5% of global cancer cases, including breast and gastric carcinomas and both Hodgkin’s and non-Hodgkin’s lymphomas, are linked with prior Epstein–Barr Virus (EBV) infection. Such properties make EBV-infected lymphocytes ideal models for understanding the effect of oxyhydrogen gas on dysfunctional cell cycling. The aim of this study is to assess the effects of the direct infusion of oxyhydrogen gas on the replicative capacity of EBV-immortalised B-lymphocytes. Oxyhydrogen gas was directly infused into cell culture media. Cells were incubated in 95% air and 5% CO2 for up to 72 h. Cell enumeration was assessed with and without the addition of mitogenic growth stimuli, and subsequent cell-cycle analysis was performed. Cell enumeration: An initial trend of replicative inhibition of TK6 cells is noted with a single oxyhydrogen treatment at the 24 and 48 h time points. The daily addition of oxyhydrogen-infused media showed statistically relevant data at 24 and 48 h but not at 72 h. In mitogen-stimulated cells, a non-statistical trend of inhibition was observed at 24, 48 and 72 h. Analysis details a significant increase in DNA in the Sub G1 phase, indicating increased apoptosis.

Journal Article Type Article
Acceptance Date Oct 2, 2023
Online Publication Date Oct 4, 2023
Publication Date Oct 4, 2023
Deposit Date Oct 6, 2023
Publicly Available Date Oct 6, 2023
Journal Hydrogen (Switzerland)
Electronic ISSN 2673-4141
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 4
Issue 4
Pages 746-759
DOI https://doi.org/10.3390/hydrogen4040047
Keywords antioxidant; anti-inflammatory; apoptosis; hydrogen; malignancy; oxyhydrogen; tumor
Public URL https://uwe-repository.worktribe.com/output/11153694
Publisher URL https://www.mdpi.com/journal/hydrogen

Files






You might also like



Downloadable Citations